ArticleISRN pharmacology2012

Short-Term Therapy with Rosiglitazone, a PPAR-γ Agonist, Improves Metabolic Profile and Vascular Function in Nonobese Lean Wistar Rats.

Mohammad M Naderali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.